Zullo Investment Group, Inc. Bristol Myers Squibb CO Transaction History

Zullo Investment Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$57.89 - $64.73 $15,167 - $16,959	262 Added 8.08%	3,506 $203,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $5,606 - $6,225	-88 Reduced 2.64%	3,244 $207,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $854 - $968	13 Added 0.39%	3,332 $230,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1,095 - $1,297	16 Added 0.48%	3,319 $238,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $7 - $4,610	60 Added 1.85%	3,303 $235,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $726 - $799	10 Added 0.31%	3,243 $250,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $614 - $737	-10 Reduced 0.31%	3,233 $236,000
Q4 2021 Feb 16, 2022	BUY	$53.63 - $62.52 $173,922 - $202,752	3,243 New	3,243 $202,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Zullo Investment Group, Inc. with notifications on news.